Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:monoclonal_antibody
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Med_Immune
|
| gptkbp:activities |
neutralizes RSV
|
| gptkbp:appointed_by |
intramuscular injection
|
| gptkbp:approves |
gptkb:U._S._Food_and_Drug_Administration_(FDA)
|
| gptkbp:developed_by |
gptkb:Med_Immune
|
| gptkbp:dosage_form |
solution for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Synagis
|
| gptkbp:indication |
premature infants
infants with certain heart conditions |
| gptkbp:is_used_for |
prevention of respiratory syncytial virus (RSV) infection
|
| gptkbp:targets |
gptkb:respiratory_syncytial_virus_(RSV)
|